Takeharu Hayashi
Overview
Explore the profile of Takeharu Hayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Inagaki N, Takei Y, Hatano T, Takada Y, Yazaki Y, Kosuge H, et al.
Mol Genet Metab Rep
. 2025 Feb;
42:101196.
PMID: 39995634
Fabry disease (FD) is an X-linked lysosomal storage disease caused by mutations in , which encodes α-galactosidase A (GLA). The loss or reduced activity of GLA leads to damage to...
2.
Inagaki N, Okano T, Kobayashi M, Fujii M, Yazaki Y, Takei Y, et al.
Hum Genome Var
. 2024 Mar;
11(1):14.
PMID: 38548731
TNNI3 is a gene that causes hypertrophic cardiomyopathy (HCM). A 14-year-old girl who was diagnosed with nonobstructive HCM presented with cardiopulmonary arrest due to ventricular fibrillation. Genetic testing revealed a...
3.
Inagaki N, Hayashi T, Takei Y, Kosuge H, Suzuki S, Tanimoto K, et al.
Hum Genome Var
. 2022 Feb;
9(1):6.
PMID: 35181673
RBM20 is a disease-causing gene associated with dilated cardiomyopathy (DCM). The proband presented with the dilated phase of hypertrophic cardiomyopathy (HCM), and the mother also suffered from HCM. A missense...
4.
Hirayama-Yamada K, Inagaki N, Hayashi T, Kimura A
Int Heart J
. 2021 Mar;
62(2):359-366.
PMID: 33678800
Dilated cardiomyopathy (DCM) is a common cause of heart failure. TTN, which encodes titin protein, is a representative causative gene of DCM, and is presented mainly as a truncation variant....
5.
Hayashi T
Keio J Med
. 2020 Apr;
69(4):77-87.
PMID: 32224552
Hypertrophic cardiomyopathy (HCM) is an intractable disease that causes heart failure mainly due to unexplained severe cardiac hypertrophy and diastolic dysfunction. HCM, which occurs in 0.2% of the general population,...
6.
Inagaki N, Hayashi T, Takei Y, Tanimoto K, Chikamori T, Kimura A
J Hum Genet
. 2018 Sep;
63(12):1273-1276.
PMID: 30206291
Hypertrophic cardiomyopathy (HCM) is characterized by unexplained left ventricular hypertrophy. This study aimed to reveal the clinical and genetic backgrounds of the unique HCM with mid-ventricular obstruction (HCM-MVO) subtype. We...
7.
Hayashi T, Tanimoto K, Hirayama-Yamada K, Tsuda E, Ayusawa M, Nunoda S, et al.
J Hum Genet
. 2018 Jun;
63(9):989-996.
PMID: 29907873
Hypertrophic cardiomyopathy (HCM) and restrictive cardiomyopathy (RCM) present a high risk for sudden cardiac death in pediatric patients. The aim of this study was to identify disease-associated genetic variants in...
8.
Murayama R, Kimura-Asami M, Togo-Ohno M, Yamasaki-Kato Y, Naruse T, Yamamoto T, et al.
Sci Rep
. 2018 Jun;
8(1):8970.
PMID: 29895960
RBM20 is a major regulator of heart-specific alternative pre-mRNA splicing of TTN encoding a giant sarcomeric protein titin. Mutation in RBM20 is linked to autosomal-dominant familial dilated cardiomyopathy (DCM), yet...
9.
Tsujii N, Hayashi T, Hayashi T, Kimura A, Nishikubo T
Pediatr Int
. 2018 Mar;
60(4):385-387.
PMID: 29508483
No abstract available.
10.
Arimura T, Muchir A, Kuwahara M, Morimoto S, Ishikawa T, Du C, et al.
Am J Physiol Heart Circ Physiol
. 2018 Feb;
314(6):H1192-H1202.
PMID: 29451818
Mutations in genes encoding components of the sarcomere cause cardiomyopathy, which is often associated with abnormal Ca sensitivity of muscle contraction. We have previously shown that a heart-specific myosin light...